21 May 2025 - Based on LAURA Phase 3 trial results which showed patients who took Targrisso after CRT had ...
17 May 2025 - US President Donald Trump has launched a new effort to lower prescription drug prices for Americans ...
13 May 2025 - The multi-dose, single-patient-use, pre-filled pen allows for personalised treatment plans that can cater to individual patient ...
8 May 2025 - ALK today announced that Health Canada has approved ALK’s regulatory filing for Itulatek (tree pollen sublingual allergy ...
5 May 2025 - Tzield is demonstrated to delay by a median of 2 years the onset of Stage 3 type ...
2 May 2025 - Today, Novo Nordisk Canada announced that Health Canada has accepted for review, under the priority review policy, ...
28 April 2025 - Iqirvo (elafibranor) is the first new medicine approved in nearly a decade for the treatment of ...
25 April 2025 - Canada’s Drug Agency has published a new position statement on the use of artificial intelligence methods ...
22 April 2025 - This is the third indication for Sarclisa in Canada for the treatment of multiple myeloma. ...
22 April 2025 - Approval is based on the results from the Phase 3 CCTG IND.227/KEYNOTE-483 trial. ...
17 April 2025 - Canada’s Drug Agency announces a new 5-year strategic plan, Insight to Impact 2025–2030. ...
17 April 2025 - Approval based on RUBY Part 1 trial, where Jemperli plus chemotherapy demonstrated a statistically significant and ...
15 April 2025 - Elyxyb is a first-line treatment and the only FDA approved, ready to use oral solution for the ...
14 April 2025 - Organon today announced that Health Canada has approved Nduvra (tapinarof cream), 1%, the first in a novel ...
10 April 2025 - Health Canada has granted a Notice of Compliance for Imfinzi (durvalumab), as monotherapy, for the treatment ...